testing programs

Making genetic testing the standard of care

Arboretum's genetic tests help doctors both diagnose and understand risk for common diseases, enabling providers to individualize patient care at scale. 

Scaling Genetic Testing

Operationally Simple,
Scientifically
Rigorous, Financially Viable

Insurance Coverage for Genetic Testing Continues to Expand

Arboretum provides genetic tests aligned to clinical guidelines and insurance medical policies. Clinical indications for hereditary disease testing are evolving faster than ever. Though coverage for genetic testing continues to expand, testing is underutilized in practice due to many operational factors.

Arboretum Enables Healthcare Systems to Deliver Precision Care

Our approach is designed around real-world healthcare system constraints. We identify the bottlenecks in each partner’s clinical setting to provide scalable solutions to support patient assessment and test ordering, including but not limited to supplemental staffing. This allows clinical teams to focus on patient care delivery, not administrative burden.

Longitudinal Patient Registry Completes the Picture of Genetic Risk

In partnership with healthcare systems, our multi-site research registry delivers emerging scientific insights like polygenic risk scores at no cost to clinically tested patients who opt in. These supplemental findings help providers better understand the true nature of genetic disease to advance research and push clinical guidelines forward, and also provide research participants genetic insights and access to early interventions in the form of clinical trials.

Our Tests

Arboretum’s world-renowned genomics expertise allows us to develop and customize clinical tests to suit your clinical champion’s needs. Learn more about our genetic testing portfolio below.

Genetic testing is available for familial hypercholesterolemia, hereditary arrhythmias, cardiomyopathies and inherited risk for common cardiac conditions. These results may enable earlier diagnosis and more targeted treatment decisions.
Genetic testing is available for inherited risk across breast, ovarian, colorectal, and other hereditary cancer syndromes. Results may inform screening schedules, chemoprevention, and surgical planning.

Our offerings

A Fully Integrated Approach to Precision Medicine

Advancing Precision Medicine at the Point of Care

  • Germline monogenic and polygenic test catalog aligned to clinical guidelines (insurance-eligible)
  • Customizable testing programs and surge capacity for clinical teams
  • Commitment to health equity: best in class handling for novel variant discovery aligned to ACMG V4 guidelines.

Accelerating Translational Research through Collaborative Registry

  • Research participants receive additional clinical test results, better understanding of their genetics, and access to personalized therapies
  • Arboretum provides secure platform for researcher analysis, no IT burden

Clinical Trial Pipelines that build Centers of Excellence

  • Arboretum identifies clinical trial opportunities personalized to the biology of research participants at each health system
  • Every trial match improves health system readiness to practice precision medicine at the point of care